Verition Fund Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.6M Sell
4,544
-37,794
-89% -$13.5M 0.01% 1124
2025
Q4
$13.9M Sell
42,338
-11,491
-21% -$3.65M 0.05% 312
2025
Q3
$15.2M Buy
53,829
+29,689
+123% +$8.61M 0.06% 299
2025
Q2
$6.74M Sell
24,140
-3,785
-14% -$1.07M 0.03% 816
2025
Q1
$8.7M Buy
27,925
+2,551
+10% +$753K 0.04% 521
2024
Q4
$6.61M Buy
25,374
+12,192
+92% +$3.62M 0.03% 728
2024
Q3
$4.25M Sell
13,182
-6,439
-33% -$2.11M 0.02% 967
2024
Q2
$6.13M Sell
19,621
-5,055
-20% -$1.49M 0.03% 606
2024
Q1
$7.02M Sell
24,676
-2,236
-8% -$654K 0.05% 487
2023
Q4
$7.75M Buy
26,912
+15,230
+130% +$4.15M 0.06% 306
2023
Q3
$3.14M Buy
11,682
+39
+0.3% +$9.73K 0.04% 612
2023
Q2
$2.58M Buy
11,643
+2,148
+23% +$498K 0.03% 568
2023
Q1
$2.3M Buy
9,495
+3,344
+54% +$821K 0.03% 658
2022
Q4
$1.62M Sell
6,151
-16,060
-72% -$4.31M 0.03% 705
2022
Q3
$5.01M Buy
22,211
+8,652
+64% +$2.1M 0.06% 407
2022
Q2
$3.3M Buy
13,559
+7,246
+115% +$1.78M 0.07% 412
2022
Q1
$1.53M Sell
6,313
-2,626
-29% -$603K 0.02% 1162
2021
Q4
$2.01M Buy
8,939
+3,964
+80% +$837K 0.01% 883
2021
Q3
$1.06M Buy
4,975
+386
+8% +$88.8K 0.01% 904
2021
Q2
$1.12M Buy
+4,589
New +$1.13M 0.01% 742
2020
Q1
Sell
-3,504
Closed -$845K 590
2019
Q4
$845K Buy
3,504
+2,172
+163% +$479K 0.02% 496
2019
Q3
$258K Sell
1,332
-6,987
-84% -$1.34M 0.01% 855
2019
Q2
$1.53M Buy
8,319
+4,221
+103% +$756K 0.04% 302
2019
Q1
$779K Buy
+4,098
New +$783K 0.03% 489
2018
Q3
Sell
-2,418
Closed -$446K 1229
2018
Q2
$446K Sell
2,418
-15,226
-86% -$2.69M 0.03% 725
2018
Q1
$3.01M Buy
17,644
+11,637
+194% +$2.14M 0.22% 83
2017
Q4
$1.04M Buy
6,007
+3,264
+119% +$578K 0.1% 236
2017
Q3
$511K Buy
2,743
+679
+33% +$120K 0.04% 562
2017
Q2
$355K Sell
2,064
-9,615
-82% -$1.56M 0.03% 600
2017
Q1
$1.92M Buy
11,679
+7,887
+208% +$1.31M 0.18% 103
2016
Q4
$554K Sell
3,792
-285
-7% -$42.9K 0.05% 511
2016
Q3
$680K Sell
4,077
-8,516
-68% -$1.44M 0.07% 348
2016
Q2
$1.92M Buy
12,593
+10,595
+530% +$1.65M 0.24% 80
2016
Q1
$300K Sell
1,998
-785
-28% -$117K 0.05% 478
2015
Q4
$452K Buy
2,783
+189
+7% +$29.7K 0.09% 216
2015
Q3
$359K Buy
2,594
+1,280
+97% +$202K 0.09% 286
2015
Q2
$202K Buy
+1,314
New +$210K 0.04% 475
2014
Q4
Sell
-3,898
Closed -$548K 355
2014
Q3
$548K Buy
3,898
+2,207
+131% +$288K 0.08% 214
2014
Q2
$200K Sell
1,691
-10,050
-86% -$1.16M 0.02% 554
2014
Q1
$1.45M Buy
11,741
+8,773
+296% +$1.06M 0.22% 76
2013
Q4
$339K Sell
2,968
-6,352
-68% -$723K 0.06% 244
2013
Q3
$1.04M Sell
9,320
-1,861
-17% -$202K 0.16% 113
2013
Q2
$1.1M Buy
+11,181
New +$1.16M 0.2% 89

Other funds holding AMGN

Verition Fund Management's AMGN Position: Q1 2026 in Review

Verition Fund Management reduced its Amgen (AMGN) stake by 89% in Q1 2026, selling an estimated $13.5M and leaving 4,544 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #1124.

Verition Fund Management first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $15.2M in Q3 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Verition Fund Management held 4,544 shares of Amgen worth $1.6M as of Q1 2026.
  • Verition Fund Management sold 37,794 Amgen shares in Q1 2026, an estimated $13.5M.
  • Amgen made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1124 holding.
  • Verition Fund Management first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
  • Verition Fund Management's Amgen position peaked at $15.2M in Q3 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.